As of Nov 19, 2026, 2 of 2 active firms rate RADX a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
Top analysts covering Radiopharm Theranostics Limited American Depositary Shares
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on RADX.
#1
RB
Robert Burns
HC Wainwright & Co. · Rank #215
Buy
$16.00+2235.4% to target
Overall win rate
42%
+ Follow
#2
YZ
Yuan Zhi
B. Riley Securities
Buy
$16.00+2235.4% to target
Coverage
—
+ Follow
#3
Michael Okunewitch
Maxim Group
Buy
$15.00+2089.5% to target
Coverage
—
+ Follow
#4
JW
Justin Walsh
JonesTrading
Buy
$30.00+4278.9% to target
Coverage
—
+ Follow
#5
KD
Kemp Dolliver
Brookline Capital
Buy
$18.00+2527.4% to target
Coverage
—
+ Follow
RADX stock forecast FAQ
What is RADX's average 12-month price target?+
The 2 active firms with a live target average $16.00 for Radiopharm Theranostics Limited American Depositary Shares over the next 12 months, ranging from a $16.00 high to a $16.00 low, as of Nov 19, 2026.
Is RADX stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover RADX?+
2 active firms have a recognized rating on Radiopharm Theranostics Limited American Depositary Shares as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering RADX?+
Among analysts who currently cover RADX, Robert Burns of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #215). Their current call is Buy with a $16.00 target.
Have analysts been upgrading or downgrading RADX lately?+
As of Nov 19, 2026, 2 of 2 active firms rate RADX a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their RADX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.